Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		18 Months Ended
	Aug. 31, 2012	Aug. 31, 2011	Aug. 31, 2012
Cash flows from operating activities
Net loss	$ (833,012)	$ (1,585,803)	$ (50,534,822)
Adjustments to reconcile net (loss) to net cash flows:
Write off of note receivable			57,500
Impairment of mineral property costs		150,000	14,421,668
Issuance of shares for consulting services			510,590
Issuance of shares for interest costs			82,500
Discount on convertible debenture			569,549
Deposit on equipment written off			25,300
Gain on disposal of assets			(15,130)
Gain on sale of assets	31,691		(4,358,263)
Non-cash component of gain on settlement of debt	208,736	(224,665)	(786,907)
Beneficial conversion feature			4,081,091
Stock-based compensation	348,000	725,725	12,588,436
Amortization	8,960	23,013	355,263
Net change in operating assets and liabilities:
Prepaid expense	46,229	61,507	(5,399)
Accounts receivable	(933,270)	(149,809)	(918,713)
Inventory	64,202
Customer deposits			(194,809)
Notes payable			109,337
Accounts payable and accrued liabilities	80,037	10,577	7,327,113
Cash used in operating activities	(978,427)	(989,455)	(16,685,696)
Sale of equipment	49,650		82,966
Purchase of property and equipment	(584)		(604,201)
Cash provided (used) in investing activities	49,066		(521,235)
Financing activities
Proceeds from loans payable			316,617
Proceeds from notes payable			3,162,196
Proceeds from convertible debentures			7,462,500
Proceeds from exercise of options			78,000
Proceeds from exercise of warrants			3,144,377
Repayment of loans payable	(12,887)	(12,876)	(309,736)
Repayment of notes payable			(586,620)
Repayment of convertible debentures			(2,051,047)
Stock subscriptions	1,008,600	670,904	3,326,862
Issuance of common stock			2,756,994
Cash provided (used) by financing activities	995,713	658,028	17,300,143
Net change in cash	66,352	(331,427)	93,212
Effect of foreign currency translation on cash	(20,659)	(132)	48,296
Cash and cash equivalents, beginning	117,892	407,912	22,077
Cash and cash equivalents, ending	$ 163,585	$ 76,353	$ 163,585